Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New JAK3 inhibitors emerge from Rigel R&D

Jan. 9, 2007

Pharmacopeia and Wyeth to develop JAK3 inhibitor products

Jan. 8, 2007

Pluristem submits pre-IND document for PLX-I

Jan. 8, 2007

Viprovex studied for adjuvant utility in pandemic influenza

Jan. 8, 2007

Grifols receives FDA approval for new generation of IVIG

Jan. 4, 2007

Novel agents for transplant rejection revealed in recent patents

Dec. 29, 2006

NIAID to study Emergent's group B streptococcus vaccine candidate

Dec. 29, 2006

Imvamune equally immunogenic in HIV-infected subjects as healthy subjects

Dec. 29, 2006

L- and P- selectin antagonists patented by GlycoMimetics

Dec. 22, 2006

Phase III study opens in U.S. for Grazax

Dec. 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...